Polycystic ovary syndrome and low-grade inflammation with special reference to YKL-40

Gynecological Endocrinology

Volumn 30, Issue 4, 2014, Pages 311-315

  Aziz, M ^a   Wissing, M L M ^b   Naver, K V ^c   Faber, J ^a   Skouby, S O ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HOLBÆK HOSPITAL   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Androgens; Body mass index; Insulin resistance; Low grade inflammation; PCOS

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INSULIN; LIPID; MEMBRANE PROTEIN; PROTEIN YKL 40; TESTOSTERONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ADIPOCYTOKINE; BIOLOGICAL MARKER; CHI3L1 PROTEIN, HUMAN; LECTIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR RISK; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERANDROGENISM; INFLAMMATION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; WAIST CIRCUMFERENCE; YOUNG ADULT; ADOLESCENT; BLOOD; CLINICAL TRIAL; DENMARK; METABOLISM; MULTICENTER STUDY; PROSPECTIVE STUDY; REGRESSION ANALYSIS;

ADIPOKINES; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LECTINS; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; TRIGLYCERIDES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84897844170     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2013.879854     Document Type: Article

References (27)

1. Fauser BC. Consensus on women's health aspects of polycystic ovary syndrome (PCOS). Hum Reprod 2012;27: 14-24.
2. Legro RS. Type 2 diabetes and polycystic ovary syndrome. Fertil Steril 2006;86:S16-17.
3. Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980;50: 113-6.
4. Orio F, Vuolo L, Palomba S, et al. Metabolic and cardiovascular consequences of polycystic ovary syndrome. Minerva Ginecol 2008; 60: 39-51.
5. Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91: 4237-45.
6. Fauser BC. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19: 41-7.
7. Carmina E, Chu MC, Longo RA, et al. Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab 2005;90: 2545-9.
8. Tosi F, Dorizzi R, Castello R, et al. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome. Eur J Endocrinol 2009;161: 737-45.
9. Samy N, Hashim M, Sayed M, Said M. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Dis Markers 2009; 26: 163-70.
10. Lemieux I, Pascot A, Prud'homme D, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001;21: 961-7.
11. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 2007;49: 2129-38.
12. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 2004;44: 6-11.
13. Rathcke CN, Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res 2006;55: 221-7.
14. Rathcke CN, Johansen JS, Vestergaard H. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflamm Res 2006;55: 53-9.
15. Boot RG, van Achterberg TA, van Aken BE, et al. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 1999;19: 687-94.
16. Hempen M, Kopp HP, Elhenicky M, et al. YKL-40 is elevated in morbidly obese patients and declines after weight loss. Obes Surg 2009;19: 1557-63.
17. Rathcke CN, Vestergaard H. YKL-40-an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol 2009; 8:61.
18. Ostergaard C, Johansen JS, Benfield T, et al. YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin Diagn Lab Immunol 2002;9: 598-604.
19. Celik C, Abali R, Guzel S, et al. Elevated circulating levels of YKL-40 are a marker of abnormal glucose tolerance in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2012;77: 893-7.
20. Aziz M, Naver KV, Wissing ML, et al, Skouby SO. Polycystic ovary syndrome: infertility, cardiovascular, metabolic and obstetrical risks, laboratory and clinical outcomes - the PICOLO Study. Gynecol Endocrinol 2012;28: 253-8.
21. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84: 3666-72.
22. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-9.
23. Novotny R, Going S, Teegarden D, et al. Hispanic and Asian pubertal girls have higher android/gynoid fat ratio than whites. Obesity (Silver Spring) 2007;15: 1565-70.
24. Rathcke CN, Persson F, Tarnow L, et al. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care 2009;32: 323-8.
25. Rathcke CN, Raymond I, Kistorp C, et al. Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population. Int J Cardiol 2010;143: 35-42.
26. Bojesen SE, Johansen JS, Nordestgaard BG. Plasma YKL-40 levels in healthy subjects from the general population. Clin Chim Acta 2011;412: 709-12.
27. Guo M, Chen ZJ, Eijkemans MJ, et al. Comparison of the phenotype of Chinese versus Dutch Caucasian women presenting with polycystic ovary syndrome and oligo/amenorrhoea. Hum Reprod 2012; 27: 1481-8.